Parkway Shanghai Hospital notched another project milestone on 16 September as its building structure was completed. The 450-bed multi-specialty hospital is expected to start seeing patients in 2022.
It will offer a comprehensive range of specialties, with a focus on cardiology, cardiac surgery, gastroenterology, urology, minimally invasive surgery, general surgery and internal medicine.
Built on a 35,754 square metre site (about five football fields), Parkway Shanghai is located in close proximity to the Shanghai Hongqiao International Airport and high speed railway station. The hospital will leverage our existing network of medical centres in Shanghai to provide integrated healthcare services for residents in the Yangtze River Delta and beyond.
Located in the medical hub of Shanghai New Hongqiao International Medical Center, Parkway Shanghai will support the Chinese government’s ambition to develop Shanghai into a world-class medical destination that attracts not only Chinese nationals, but also expatriates and medical tourists alike.
The hospital is a joint venture between IHH Healthcare, Taikang Insurance Group and Shanghai Hongxin Medical Investment Holding.
Related Stories
Gleneagles BGS Champions Spine Health and Recovery
Gleneagles BGS Hospital brought together patients, clinicians and spine health advocates to celebrate life after spinal surgery while raising awareness of early diagnosis and timely intervention.
Pantai KL Brings Cancer Care Closer to More Communities
Pantai Hospital Kuala Lumpur has strengthened its oncology services with the soft launch of the Pantai Oncology Daycare Centre in Cheras, bringing cancer treatment closer to patients and families.
Gleneagles JPMC Strengthens Regional Cardiac Collaboration
Gleneagles JPMC joined leading cardiac professionals at the 30th ASEAN Federation of Cardiology Congress, supporting knowledge exchange and regional collaboration to advance cardiovascular care across ASEAN.
Gleneagles Hong Kong Advances Healthier Ageing Through Innovation
Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.
Turning Clinical Insights into Better Patient Outcomes
.jpg?sfvrsn=745604e1_1)
Gleneagles Hong Kong Leads the Way in Advancing Liver Cancer Care
Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
